4 Nov 2022 , 07:27 AM
On the first day of the offer on Thursday, 26% of Global Health’s initial public offering (IPO), which runs hospitals under the Medanta name, was subscribed.
According to information available with the NSE, the company’s IPO attracted bids for 1,19,502,688 shares versus the 4,67,42,397 shares on offer. Retail Individual Investors (RIIs) made up 12% of the total subscriptions, followed by Non-Institutional Investors (18%) and Qualified Institutional Buyers (QIBs) (54%).
A fresh issue of up to Rs 500 crore and an offer to sell up to 5,07,61,000 equity shares are both included in the IPO. It trades for between Rs 319 and Rs 336 per share. On Wednesday, Global Health said that it had raised Rs 662 crore from key investors. The company is anticipated to receive Rs 2,206 crore at the top of the pricing range through the IPO.
The fresh issue’s proceeds will be used for general corporate operations and debt repayment. A premier private multi-specialty tertiary care provider in the north and east of India, Global Health was established by renowned cardiovascular and cardiothoracic surgeon Dr. Naresh Trehan.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.